COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,355 Articles (22,803 medRxiv, 8,552 bioRxiv)

Most recent first Previous |  Page 2992: Articles 29911-29920  | Next

Evaluation of heating and chemical protocols for inactivating SARS-CoV-2
Pastorino, B., Touret, F., Gilles, M., de Lamballerie, X., Charrel, R. N.
10.1101/2020.04.11.036855 — Posted: 2020-04-11 Discussion: Onsite
Three adjacent nucleotide changes spanning two residues in SARS-CoV-2 nucleoprotein: possible homologous recombination from the transcription-regulating sequence
Leary, S., Gaudieri, S., Chopra, A., Pakala, S., Alves, E., John, M., Das, S., Mallal, S., Phillips, P. J.
10.1101/2020.04.10.029454 — Posted: 2020-04-11
Cell-Type-Specific Expression of Renin-Angiotensin-System Components in the Human Body and Its Relevance to SARS-CoV-2 Infection
Suryawanshi, H., Morozov, P., Tuschl, T., Muthukumar, T., tenOever, B. R., Yamaji, M., Williams, Z.
10.1101/2020.04.11.034603 — Posted: 2020-04-11
Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy.
Pollard, H. B., Pollard, B. S., Pollard, J. R.
10.1101/2020.04.09.034983 — Posted: 2020-04-11
A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity
Saha, P., Banerjee, A. K., Tripathi, P. P., Srivastava, A. K., Ray, U.
10.1101/2020.04.07.029132 — Posted: 2020-04-11
In-depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles
Bartas, M., Brazda, V., Bohalova, N., Cantara, A., Volna, A., Stachurova, T., Malachova, K., Jagelska, E. B., Porubiakova, O., Cerven, J., Pecinka, P.
10.1101/2020.04.09.031252 — Posted: 2020-04-11
Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach
Lokman, S. M., Rasheduzzaman, M., Salauddin, A., Barua, R., Tanzina, A. Y., Rumi, M. H., Hossain, M. I., Siddiki, A. Z., Mannan, A., Hasan, M. M.
10.1101/2020.04.07.030924 — Posted: 2020-04-11
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
Kumar, N., Mishra, B., Mehmood, A., Athar, M., Mukhtar, M. S.
10.1101/2020.04.09.033910 — Posted: 2020-04-11
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1
Li, Y., Wang, H., Tang, X., Ma, D., Du, C., Wang, Y., Pan, H., Zou, Q., Zheng, J., Xu, L., Farzan, M., Zhong, G.
10.1101/2020.04.10.032342 — Posted: 2020-04-11 Discussion: Onsite
De novo design of high-affinity antibody variable regions (scFv) against the SARS-CoV-2 spike protein
Boorla, V. S., Chowdhury, R., Maranas, C. D.
10.1101/2020.04.09.034868 — Posted: 2020-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).